(Q38408563)

2 September 2017

0 references

1 reference

title

The use of ketamine as an antidepressant: a systematic review and meta-analysis (English)

1 reference

2 September 2017

1 reference

1 reference

Caoimhe M Coyle

1

1 reference

2 September 2017

Keith R Laws

series ordinal

2

1 reference

2 September 2017

publication date

7 April 2015

1 reference

2 September 2017

published in

Human Psychopharmacology

1 reference

2 September 2017

volume

30

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

152-163

1 reference

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression

2 September 2017

cites work

1 reference

Ketamine for depression: where do we go from here?

21 January 2018

1 reference

Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting

21 January 2018

1 reference

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.

21 January 2018

1 reference

Sex differences in the antidepressant-like effects of ketamine

21 January 2018

1 reference

Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression

21 January 2018

1 reference

Therapeutic infusions of ketamine: do the psychoactive effects matter?

21 January 2018

1 reference

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

21 January 2018

1 reference

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder

21 January 2018

1 reference

Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder

21 January 2018

1 reference

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

21 January 2018

1 reference

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

Associative blocking to reward-predicting cues is attenuated in ketamine users but can be modulated by images associated with drug use.

21 January 2018

1 reference

Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study

21 January 2018

1 reference

Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression

21 January 2018

1 reference

A randomized controlled trial of intranasal ketamine in major depressive disorder

21 January 2018

1 reference

A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department

21 January 2018

1 reference

Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression

21 January 2018

1 reference

Neuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trial.

21 January 2018

1 reference

Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression

21 January 2018

1 reference

Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial

21 January 2018

1 reference

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

21 January 2018

Ketamine use: a review

1 reference

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression

21 January 2018

1 reference

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial

21 January 2018

1 reference

Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder

21 January 2018

1 reference

Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist

21 January 2018

1 reference

Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression

21 January 2018

1 reference

Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression

21 January 2018

1 reference

Serial infusions of low-dose ketamine for major depression

21 January 2018

1 reference

Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved?

21 January 2018

1 reference

Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine.

21 January 2018

1 reference

Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine.

21 January 2018

1 reference

Ketamine as a fast acting antidepressant: current knowledge and open questions.

21 January 2018

1 reference

Rapid Antidepressant Response with Ketamine: Is it the Solution to Resistant Depression?

21 January 2018

1 reference

Increased response to ketamine following treatment at long intervals: implications for intermittent use.

21 January 2018

1 reference

Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin

21 January 2018

1 reference

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

21 January 2018

1 reference

Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression

21 January 2018

1 reference

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/HUP.2475

1 reference

2 September 2017

1 reference